Author: Neel Achary

ten23 health® strengthens leadership team to drive its next stage of growth

Basel, Switzerland, May 26: ten23 health®, the human-centric and sustainable strategic CDMO partner of choice for the pharmaceutical industry and biotech start-ups, today announced changes to its leadership team as part of its ongoing commitment to position the company for further long-term growth. These updates reflect a thoughtful alignment of leadership to support the continued expansion of ten23’s capabilities and manufacturing capacity.

From May 1^st, 2026, Andrea Wesp assumed responsibility as Chief Business Officer (CBO). Andrea brings broad experience as a global business leader, having led large international organizations through strategic transformation, innovation and sustainable growth. She combines deep commercial acumen with technical and operational expertise across the pharmaceutical and CDMO value chain. Andrea joins ten23 from Siegfried, where she served as VP Market Development BD & Sales Drug Products. Prior to that, she held a range of roles, including VP New Business Development at Vetter Pharma, and VP Sterile Solutions/BU Pharmaceutical Systems at Schott Pharma. She holds a chemical and process engineering degree from the Technical University of Hamburg, and a business economics degree from FU Hagen in Germany.

Stephanie Knüppel assumed the role of Chief Operating Officer (COO) on April 1^st, 2026, after joining ten23 in in June 2025 as Chief of Staff to the COO. She brings extensive experience in leading manufacturing and operations teams, along with strong sterile product knowledge. As E2E Value Stream Lead (Head) of Manufacturing & Packaging Operations at the Roche Kaiseraugst commercial production site, she was responsible for launches, tech transfer and industrialization, and gained extensive experience in compounding, sterile aseptic manufacturing, visual inspection, validation/qualification, device combination products, supply chain resilience, Annex 1 and regulatory authority inspections. Stephanie studied chemistry and holds a PhD from the University of Münster in Germany.

Susanne Jörg, who previously held the position as COO, began her new role as Chief of Staff to the CEO on April 1^st, 2026. Before joining ten23 health in 2021 as COO, Susanne held several senior positions in Lonza and Novartis. She has over 15 years’ experience in formulation development, process development, transfer and validation, sterile manufacturing and regulatory submissions for early-, late-stage and life-cycle parenteral dosage forms. As the new Chief of Staff, Susanne will support ten23’s CEO Hanns-Christian Mahler in strategic initiatives, and will be instrumental in preparing the company for its future growth.

From March 1^st, 2026, Felicia Werk assumed the role as Chief People & Culture Officer. Felicia joined ten23 in May 2022 to lead ten23’s Learning & Development activities. She previously held a range of senior positions at Bayer, including Global HR Change and Transformation Lead, Head of Business Development, Operational Excellence Manager, Strategy Deployment Lead, and People and Organizational Development Lead. She holds a master’s degree in business psychology from the University of Trier in Germany and an MBA from Heriot-Watt University in the UK.

Alessandra Seriacopi joined ten23 as Chief Quality Officer (CQO) in September 2025. Alessandra brings over 20 years’ experience in quality leadership across the pharmaceuticals, biotech, and vaccines sectors. She was previously Senior Quality Director Drug Product Division EU and APAC at Thermo Fisher Scientific, and held senior roles at MSD, Novartis, and GSK, where she led global quality operations, regulatory compliance, and successful product launches. Alessandra has profound expertise in GMP quality systems, regulatory inspections, and managing complex CDMO environments. She holds a master’s degree in chemistry from the University di Siena in Italy.

The recent appointments are complemented by (in sequence of tenure at ten23) Andrea Allmendinger, Chief Scientific Officer (CSO), Patrick Klassnitz, Chief Finance Officer (CFO), Alissa Monk, Head of Fairstainability, and Creixell Espilla-Gilart, Chief Marketing Officer.

“We are delighted to welcome our newly appointed leaders. Together, they will bring deep and diverse industry expertise, proven execution, and different perspectives that are unique in the CDMO space. The new leadership team will accelerate our next growth stage, support our expansion, and ensure an agile focus on operational excellence and customer needs,” said Hanns-Christian Mahler, Chief Enablement Officer (CEO) at ten23 health.

He continued, “I am confident that this leadership evolution will enhance the way we support and serve our customers and their patients, unlock new opportunities, and build on our strong foundation for continued success and the next stage of growth.”

Moneycontrol Eco Pulse rises to 51.6 in April as exports, manufacturing lift activity

Index returns to expansion zone despite West Asia disruptions; exports, PMI strength and rural demand offset softer urban consumption

India, 26th May 2026: India’s economy performed better in April, with the Moneycontrol Eco Pulse Index rising to 51.6 from 49.2 in the previous month, despite disruptions from the West Asia crisis continuing for yet another month.

A reading above 50 signals expansion, indicating that economic momentum recovered after March’s contraction as manufacturing, exports and parts of domestic consumption continued to support activity.

What’s moving the index?

The recovery was led by an improvement in business activity. Manufacturing PMI rose to 54.7 in April from 53.9 in March, while services PMI improved to 58.8 from 57.5. The composite PMI also rose to 58.2, suggesting that private-sector activity remained resilient despite global uncertainty.

Exports provided a major boost after March’s weakness. Merchandise exports grew 13.8 percent in April, compared with a contraction of 7.4 percent in the previous month.

Consumption indicators remained supportive, although momentum moderated in some segments. Four-wheeler sales grew 11.6 percent, slower than 25.8 percent in March, while two-wheeler sales rose 13 percent compared with 29.5 percent earlier. Tractor sales, however, strengthened to 24.5 percent, pointing to stronger rural demand.

Financial activity stayed firm. Non-food credit grew 16.3 percent, while UPI volumes rose 24.9 percent, higher than 23.7 percent in March. However, credit card payments slowed sharply to 0.7 percent from 7.1 percent, indicating some softness in discretionary urban spending.

Infrastructure indicators showed only a modest improvement. Core sector output rose 1.7 percent in April, compared with 1.2 percent in March, while electricity demand growth improved to 3.9 percent from 1.7 percent. Major port cargo traffic also rose by 2.5 percent.

Labour market indicators were mixed. Urban unemployment eased to 6.6 percent from 6.8 percent, while youth unemployment declined to 18 percent from 18.4 percent. However, the Naukri Job Speak Index slowed to 5.8 percent, suggesting moderation in formal hiring momentum.

Inflation remained a key pressure point. Wholesale inflation accelerated to 8.3 percent in April from 3.9 percent in March, reflecting the impact of higher commodity prices and supply disruptions linked to the West Asia crisis.

The April reading suggests that India’s economy regained momentum after March’s contraction, but the recovery remains uneven. Manufacturing, exports and rural demand supported the index, while softer credit card spending, slower e-way bill growth and weak fuel indicators pointed to areas of caution.

The government allowed some pass-through of crude prices, with pump prices rising by nearly Rs 4 for both diesel and petrol. The increased prices are likely to start reflecting in consumption, with no end to the West Asia crisis in sight as yet.

Moreover, adverse weather conditions, such as El Niño, may hamper rural consumption.

The Moneycontrol Eco Pulse tracks high-frequency indicators across consumption, manufacturing, labour markets, trade and financial activity to provide an early monthly snapshot of India’s economic momentum ahead of official GDP releases.